123 related articles for article (PubMed ID: 34087781)
21. Expression of CD44 is associated with a metastatic pattern of human neuroblastoma cells in a SCID mouse xenograft model.
Valentiner U; Valentiner FU; Schumacher U
Tumour Biol; 2008; 29(3):152-60. PubMed ID: 18612220
[TBL] [Abstract][Full Text] [Related]
22. The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing.
Mühlethaler-Mottet A; Liberman J; Ascenção K; Flahaut M; Balmas Bourloud K; Yan P; Jauquier N; Gross N; Joseph JM
PLoS One; 2015; 10(5):e0125616. PubMed ID: 25955316
[TBL] [Abstract][Full Text] [Related]
23. Identification of miRNAs that are associated with tumor metastasis in neuroblastoma.
Guo J; Dong Q; Fang Z; Chen X; Lu H; Wang K; Yin Y; Cai X; Zhao N; Chen J; Zen K; Zhang J; Zhang CY
Cancer Biol Ther; 2010 Mar; 9(6):446-52. PubMed ID: 20147780
[TBL] [Abstract][Full Text] [Related]
24. NBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrest.
Andries V; Vandepoele K; Staes K; Berx G; Bogaert P; Van Isterdael G; Ginneberge D; Parthoens E; Vandenbussche J; Gevaert K; van Roy F
BMC Cancer; 2015 May; 15():391. PubMed ID: 25958384
[TBL] [Abstract][Full Text] [Related]
25. Unraveling the Enigmatic Origin of Neuroblastoma.
Liu Z; Thiele CJ
Cancer Cell; 2020 Nov; 38(5):618-620. PubMed ID: 33171126
[TBL] [Abstract][Full Text] [Related]
26. Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease.
Ramraj SK; Aravindan S; Somasundaram DB; Herman TS; Natarajan M; Aravindan N
Oncotarget; 2016 Apr; 7(14):18605-19. PubMed ID: 26921195
[TBL] [Abstract][Full Text] [Related]
27. RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model.
Byrne FL; Yang L; Phillips PA; Hansford LM; Fletcher JI; Ormandy CJ; McCarroll JA; Kavallaris M
Oncogene; 2014 Feb; 33(7):882-90. PubMed ID: 23396365
[TBL] [Abstract][Full Text] [Related]
28. Involvement of Gas7 in nerve growth factor-independent and dependent cell processes in PC12 cells.
Chao CC; Su LJ; Sun NK; Ju YT; Lih JC; Lin-Chao S
J Neurosci Res; 2003 Oct; 74(2):248-54. PubMed ID: 14515354
[TBL] [Abstract][Full Text] [Related]
29. A NOTCH3 transcriptional module induces cell motility in neuroblastoma.
van Nes J; Chan A; van Groningen T; van Sluis P; Koster J; Versteeg R
Clin Cancer Res; 2013 Jul; 19(13):3485-94. PubMed ID: 23649002
[TBL] [Abstract][Full Text] [Related]
30. The metastatic microenvironment: lung-derived factors control the viability of neuroblastoma lung metastasis.
Maman S; Edry-Botzer L; Sagi-Assif O; Meshel T; Yuan W; Lu W; Witz IP
Int J Cancer; 2013 Nov; 133(10):2296-306. PubMed ID: 23649556
[TBL] [Abstract][Full Text] [Related]
31. Growth arrest-specific protein 7 regulates the murine M1 alveolar macrophage polarization.
Xu Q; Liu X; Wang X; Hua Y; Wang X; Chen J; Li J; Wang Y; Stoeger T; Chen S; Huang N
Immunol Res; 2017 Oct; 65(5):1065-1073. PubMed ID: 28895026
[TBL] [Abstract][Full Text] [Related]
32. The gas7 protein potentiates NGF-mediated differentiation of PC12 cells.
Lortie K; Huang D; Chakravarthy B; Comas T; Hou ST; Lin-Chao S; Morley P
Brain Res; 2005 Mar; 1036(1-2):27-34. PubMed ID: 15725398
[TBL] [Abstract][Full Text] [Related]
33. Growth, progression and chromosome instability of Neuroblastoma: a new scenario of tumorigenesis?
Tonini GP
BMC Cancer; 2017 Jan; 17(1):20. PubMed ID: 28056863
[TBL] [Abstract][Full Text] [Related]
34. Effect of hypoxia on the tumor phenotype: the neuroblastoma and breast cancer models.
Holmquist L; Löfstedt T; Påhlman S
Adv Exp Med Biol; 2006; 587():179-93. PubMed ID: 17163166
[TBL] [Abstract][Full Text] [Related]
35. Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma.
Berwanger B; Hartmann O; Bergmann E; Bernard S; Nielsen D; Krause M; Kartal A; Flynn D; Wiedemeyer R; Schwab M; Schäfer H; Christiansen H; Eilers M
Cancer Cell; 2002 Nov; 2(5):377-86. PubMed ID: 12450793
[TBL] [Abstract][Full Text] [Related]
36. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
[TBL] [Abstract][Full Text] [Related]
37. The long non-coding RNA GAS5 differentially regulates cell cycle arrest and apoptosis through activation of BRCA1 and p53 in human neuroblastoma.
Mazar J; Rosado A; Shelley J; Marchica J; Westmoreland TJ
Oncotarget; 2017 Jan; 8(4):6589-6607. PubMed ID: 28035057
[TBL] [Abstract][Full Text] [Related]
38. Cancer evolution, mutations, and clonal selection in relapse neuroblastoma.
Schulte M; Köster J; Rahmann S; Schramm A
Cell Tissue Res; 2018 May; 372(2):263-268. PubMed ID: 29478075
[TBL] [Abstract][Full Text] [Related]
39. Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in neuroblastoma.
Tacconelli A; Farina AR; Cappabianca L; Gulino A; Mackay AR
Future Oncol; 2005 Oct; 1(5):689-98. PubMed ID: 16556046
[TBL] [Abstract][Full Text] [Related]
40. miR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A.
Yang H; Li Q; Zhao W; Yuan D; Zhao H; Zhou Y
FEBS Lett; 2014 Jan; 588(1):192-7. PubMed ID: 24316513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
